205 related articles for article (PubMed ID: 6930678)
1. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
[TBL] [Abstract][Full Text] [Related]
2. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
Berkowitz LR; Orringer EP
J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
[TBL] [Abstract][Full Text] [Related]
3. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
Berkowitz LR; Orringer EP
Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
[TBL] [Abstract][Full Text] [Related]
4. Effect of cetiedil on cation and water movements in erythrocytes.
Schmidt WF; Asakura T; Schwartz E
J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of erythrocyte calcium transport by cetiedil.
Levine SN; Berkowitz LR; Orringer EP
Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the mechanism by which cetiedil inhibits sickling.
Abu-Salah KM; Gambo AH
Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
[TBL] [Abstract][Full Text] [Related]
7. The effect of cetiedil on red cell membrane permeability.
Schmidt WF; Asakura T; Schwartz E
Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of sickling.
Mentzer WC
Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
[TBL] [Abstract][Full Text] [Related]
9. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
Stuart J; Stone PC; Bilto YY; Keidan AJ
J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
[TBL] [Abstract][Full Text] [Related]
10. Effects of cetiedil on the oxidative metabolism of activated polymorphonuclear leucocytes.
Kohzaki H; Kakinuma K; Asakura T; Yamakawa T
Br J Haematol; 1985 Jul; 60(3):531-9. PubMed ID: 4015989
[TBL] [Abstract][Full Text] [Related]
11. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.
Roxburgh CJ; Ganellin CR; Shiner MA; Benton DC; Dunn PM; Ayalew Y; Jenkinson DH
J Pharm Pharmacol; 1996 Aug; 48(8):851-7. PubMed ID: 8887737
[TBL] [Abstract][Full Text] [Related]
13. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
[TBL] [Abstract][Full Text] [Related]
14. Antisickling effects of membrane-interacting compounds.
Ohnishi ST
Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
[TBL] [Abstract][Full Text] [Related]
15. Cetiedil-induced increase in water exchange in sickle cell anemia erythrocytes.
Narasimhan C; Fung LW
J Pharm Sci; 1991 Nov; 80(11):1101-2. PubMed ID: 1815064
[No Abstract] [Full Text] [Related]
16. Cetiedil inhibition of calmodulin-stimulated enzyme activity.
Levine SN; Berkowitz LR; Orringer EP
Biochem Pharmacol; 1984 Feb; 33(4):581-4. PubMed ID: 6231031
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant.
Sablayrolles M; Wajcman H; Castaigne JP; Labie D
Haematologia (Budap); 1984; 17(2):199-207. PubMed ID: 6534828
[TBL] [Abstract][Full Text] [Related]
18. Molecular properties of cetiedil and its interactions with erythrocyte membranes.
Narasimhan C; Fung LW
J Pharm Sci; 1986 Jul; 75(7):654-9. PubMed ID: 3020225
[TBL] [Abstract][Full Text] [Related]
19. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.
Abdulmalik O; Pagare PP; Huang B; Xu GG; Ghatge MS; Xu X; Chen Q; Anabaraonye N; Musayev FN; Omar AM; Venitz J; Zhang Y; Safo MK
Sci Rep; 2020 Nov; 10(1):20277. PubMed ID: 33219275
[TBL] [Abstract][Full Text] [Related]
20. Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
Sablayrolles M; Wajcman H; Castaigne JP; Labie D
Am J Hematol; 1985 Feb; 18(2):121-30. PubMed ID: 3970009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
